DB LAB A/S: Financial statements 2012
CVR: 73109310
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
DB LAB A/S (CVR 73109310) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 17,930,586 and a net result of DKK 1,803,115. Equity in the 2012 report amounted to DKK 4,968,225. The solvency ratio was 14.8%.
- Gross Profit
- DKK 17,930,586
- Profit/Loss
- DKK 1,803,115
- Equity
- DKK 4,968,225
- Total Assets
- DKK 33,499,583
Official annual report
Keep an eye on DB LAB A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 22, 2012, Lisbeth Dahl Sørensen has joined the board of directors of DB LAB A/S.
About DB LAB A/S
DB LAB A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 1982. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORFERM DANMARK A/S and DANSK BIOPROTEIN A/S. The management consists of Bo Fredrik Johansson. The board consists of Sten Rickard Olofsson (chair), Bo Fredrik Johansson and Hilmir Thor Omarsson. The company is owned by ALS DENMARK A/S. The company has 34 employees (2026). In 2026, the company reported a gross profit of DKK 20,787,482 and a net result of DKK -50,685 compared with DKK 1,306,392 the year before. Equity in the 2026 report amounted to DKK 21,752,620.